CervoMed completes enrollment in phase 2a nfvPPA trial

🌐 Investing.com (CY) —
CervoMed completes enrollment in phase 2a nfvPPA trial

AI Summary

CervoMed completed enrollment in its phase 2a clinical trial for non-fluent variant primary progressive aphasia (nfvPPA). This progress marks an important milestone in developing treatments for neurodegenerative conditions.

Markets Health clinical trial CervoMed healthcare nfvPPA neurodegenerative disease drug development

Read original source →